SG48723A1 - Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use - Google Patents
Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such useInfo
- Publication number
- SG48723A1 SG48723A1 SG1996000629A SG1996000629A SG48723A1 SG 48723 A1 SG48723 A1 SG 48723A1 SG 1996000629 A SG1996000629 A SG 1996000629A SG 1996000629 A SG1996000629 A SG 1996000629A SG 48723 A1 SG48723 A1 SG 48723A1
- Authority
- SG
- Singapore
- Prior art keywords
- bilobalide
- derivatives
- compositions adapted
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241000233872 Pneumocystis carinii Species 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929202993A GB9202993D0 (en) | 1992-02-13 | 1992-02-13 | Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG48723A1 true SG48723A1 (en) | 1998-05-18 |
Family
ID=10710286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996000629A SG48723A1 (en) | 1992-02-13 | 1993-02-12 | Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5264216A (de) |
| EP (1) | EP0556051B1 (de) |
| JP (1) | JP3156212B2 (de) |
| KR (1) | KR100251394B1 (de) |
| AT (1) | ATE152911T1 (de) |
| CA (1) | CA2089309C (de) |
| DE (1) | DE69310565T2 (de) |
| DK (1) | DK0556051T3 (de) |
| ES (1) | ES2103422T3 (de) |
| GB (1) | GB9202993D0 (de) |
| GR (1) | GR3023414T3 (de) |
| SG (1) | SG48723A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379714B1 (en) | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| US6036696A (en) | 1997-12-19 | 2000-03-14 | Stryker Technologies Corporation | Guide-pin placement device and method of use |
| JP2008532707A (ja) * | 2005-03-17 | 2008-08-21 | スミス アンド ネフュー インコーポレーテッド | 医療固定部材配置システム |
| KR102858162B1 (ko) | 2020-09-25 | 2025-09-09 | 씨제이제일제당 (주) | 은행잎을 포함하는 항콕시듐용 조성물 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
| IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
-
1992
- 1992-02-13 GB GB929202993A patent/GB9202993D0/en active Pending
- 1992-03-25 US US07/857,220 patent/US5264216A/en not_active Expired - Lifetime
-
1993
- 1993-02-11 CA CA002089309A patent/CA2089309C/en not_active Expired - Fee Related
- 1993-02-12 SG SG1996000629A patent/SG48723A1/en unknown
- 1993-02-12 DE DE69310565T patent/DE69310565T2/de not_active Expired - Fee Related
- 1993-02-12 DK DK93301010.0T patent/DK0556051T3/da active
- 1993-02-12 JP JP06239393A patent/JP3156212B2/ja not_active Expired - Fee Related
- 1993-02-12 EP EP93301010A patent/EP0556051B1/de not_active Expired - Lifetime
- 1993-02-12 ES ES93301010T patent/ES2103422T3/es not_active Expired - Lifetime
- 1993-02-12 AT AT93301010T patent/ATE152911T1/de not_active IP Right Cessation
- 1993-02-13 KR KR1019930002025A patent/KR100251394B1/ko not_active Expired - Fee Related
-
1997
- 1997-05-15 GR GR960403639T patent/GR3023414T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3156212B2 (ja) | 2001-04-16 |
| ATE152911T1 (de) | 1997-05-15 |
| DK0556051T3 (da) | 1997-07-28 |
| KR100251394B1 (ko) | 2000-05-01 |
| CA2089309A1 (en) | 1993-08-14 |
| GR3023414T3 (en) | 1997-08-29 |
| US5264216A (en) | 1993-11-23 |
| EP0556051B1 (de) | 1997-05-14 |
| HK1000276A1 (en) | 1998-02-20 |
| CA2089309C (en) | 2004-11-30 |
| DE69310565T2 (de) | 1997-12-18 |
| JPH0624974A (ja) | 1994-02-01 |
| GB9202993D0 (en) | 1992-03-25 |
| EP0556051A1 (de) | 1993-08-18 |
| DE69310565D1 (de) | 1997-06-19 |
| ES2103422T3 (es) | 1997-09-16 |
| KR930017577A (ko) | 1993-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179040T3 (es) | Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b. | |
| EP0513702A3 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| ATE211387T1 (de) | Oral 1alpha-hydroxyprevitamin d | |
| MY105121A (en) | Pharmaceutical composition for systemic transdermal administration. | |
| EP0449247A3 (en) | Pharmaceutical composition containing galanthamine for treating alcoholism | |
| TR199900413T2 (xx) | �laca diren�li streptokoklar�n neden oldu�u pn�moni (pn�mokok) tedavisi i�in bir ila� yap�m�nda bir amoksisilin ve klavulanat kombinasyonunun kullan�m�. | |
| DE69307977D1 (de) | Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen | |
| MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
| IT1235153B (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento | |
| ATE173627T1 (de) | Medizinische zusammensetzung | |
| ITRM910002A1 (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
| CA2030962A1 (en) | Improvements relating to the administration of pharmaceutical agents | |
| GR1000419B (el) | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. | |
| DK0437294T3 (da) | Orale farmaceutiske præparater i enhedsdosisform | |
| GB9202993D0 (en) | Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use | |
| ATE145333T1 (de) | Hirudin enthaltende orale arzneimittel | |
| CA2113080A1 (en) | Topical composition containing penciclovir | |
| IT1249060B (it) | Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche. | |
| IT1272762B (it) | Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| ATE181828T1 (de) | Oral anzuwendendes arzneimittel bestehend aus ibuprofen | |
| IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi | |
| EP1250926A3 (de) | Die Verwendung von wasserunlöslichem S-Camptothecin mit geschlossenem Lactonring für die Herstellung eines Medikamentes zur Behandlung von Darmkrebs | |
| ES2057542T3 (es) | Agentes terapeuticos. | |
| NO920719L (no) | Injiserbare s-adenosyl-l-metionin-holdige preparater |